5-(4-ethoxyphenyl)-1,3,4-oxadiazole-2-thiol, 95.0%, 250mg

5-Cyclopropyl-2-methoxynicotinaldehyde, 95.0%, 1g

4-(S-Methylsulfonimidoyl)phenol, 95%, 250mg

N-(5-Chloro-1,3-benzodioxol-4-yl)-7-[2-(4-methyl-1-piperazinyl)ethoxy]-5-[(tetrahydro-2H-pyran-4-yl)oxy]-4-quinazolinamine, 10mg

2-Chloro-3-fluorobenzoyl chloride, 97.0%, 5g

Homophthalic acid, 97.0%, 500g

3-(2-bromophenyl)-1-ethylpiperazine dihydrochloride, 95.0%, 250mg

(6R,7R)-7-[[(2R)-2-Amino-2-phenylacetyl]amino]-3-methyl-8-oxo-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylic acid, 98%, 5g

5-(chloromethyl)-3-(2-methoxyethyl)-1,2,4-oxadiazole, 95.0%, 5g

3-[4-Methoxy-3-(piperidine-1-sulfonyl)-phenyl]-acrylic acid, 95.0%, 2.5g

Anti-Influenza A Virus Neuraminidase N2 Monoclonal Antibody (Preservative : 0.05% NaN3, Stabilizer : 1% BSA)0.2mL

4-bromo-1H-pyrrolo[2,3-b]pyridine-6-carbonitrile, 95.0%, 100mg

5-Chloro-1H-imidazo[4,5-b]pyridine-2-carboxylic acid, 95.0%, 100mg